BCIQ Profiles

Company Profile ReportTarget Profile Report

Hillhouse, Quan lead $93M series B for immuno-oncology play NextCure

NextCure Inc. (Beltsville, Md.) raised $93 million on Nov. 13 in a series B round led by new investors Hillhouse Capital Management and Quan Capital to fund development of its two lead immuno-oncology candidates.

PD-1 pioneer Lieping

Read the full 361 word article

How to gain access

Continue reading with a
two-week free trial.